Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizo-Affective Type of Psychosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00498550
What this trial is testing

Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual

Who this might be right for
SchizophreniaDual DiagnosisSchizoaffective Disorder+2 more
Dartmouth-Hitchcock Medical Center 31
Not applicableNot Yet RecruitingNCT06964477
What this trial is testing

A Trial of Extended Reality Activities to Enhance Leisure Participation Among Inpatients With Persistent Mental Health Conditions

Who this might be right for
Schizophrenia and Related DisordersMental DisordersInpatients
Chia-Hui Hung 25
Testing effectiveness (Phase 2)Looking for participantsNCT04887792
What this trial is testing

Acetazolamide for Treatment Resistant Schizophrenia

Who this might be right for
SchizophreniaSchizo Affective Disorder
Vishwajit Nimgaonkar, MD PhD 60
Large-scale testing (Phase 3)Study completedNCT00641745
What this trial is testing

Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sumitomo Pharma America, Inc. 629
Not applicableStudy completedNCT03388554
What this trial is testing

The Effects of tDCS on Auditory Hallucination, Insight, Neurocognitive Function and HRV in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderAuditory Hallucination, Verbal+4 more
Tri-Service General Hospital (TSGH) 60
Testing effectiveness (Phase 2)Looking for participantsNCT03971487
What this trial is testing

Ocrelizumab for Psychosis by Autoimmunity

Who this might be right for
Schizo-Affective Type of PsychosisSchizophrenia
The Methodist Hospital Research Institute 40
Testing effectiveness (Phase 2)Study completedNCT01720316
What this trial is testing

Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders

Who this might be right for
Schizo-affective DisorderBipolar Disorder
Mclean Hospital 2
Not applicableStudy completedNCT01003132
What this trial is testing

Assessing the Effectiveness of Acceptance and Commitment Therapy for Distress Following Psychosis

Who this might be right for
PsychosisSchizophreniaBipolar Disorder+1 more
University of Glasgow 27
Post-approval studies (Phase 4)Study completedNCT06664138
What this trial is testing

Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment

Who this might be right for
Schizophenia DisorderMajor Depression DisordersSchizoaffective Disorder+1 more
Yeongseok Yun 30
Post-approval studies (Phase 4)WithdrawnNCT00672464
What this trial is testing

Cardio Risk of Acute Schizophrenia Olanzapine Duke

Who this might be right for
SchizophreniaSchizoaffective Disorder
Duke University
Post-approval studies (Phase 4)Study completedNCT00595504
What this trial is testing

Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Massachusetts General Hospital 25
Not applicableLooking for participantsNCT07696000
What this trial is testing

The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic Therapy

Who this might be right for
Schizophrenia / Schizoaffective Disorder
DINA KEUMALA SARI 100
Testing effectiveness (Phase 2)Ended earlyNCT00686699
What this trial is testing

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Who this might be right for
Akathisia, Drug-InducedDyskinesia, Drug-InducedParkinsonian Disorders
Merck Sharp & Dohme LLC 11
Not applicableStudy completedNCT00818298
What this trial is testing

24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

Who this might be right for
SchizophreniaSchizoaffective Disorder
Centre for Addiction and Mental Health 12
Testing effectiveness (Phase 2)Study completedNCT00139906
What this trial is testing

Twice Daily Titration Study of Bifeprunox in Subjects With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Solvay Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00212784
What this trial is testing

Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)

Who this might be right for
SchizophreniaSchizoaffective Disorder
Organon and Co 1,225
Not applicableStudy completedNCT03534921
What this trial is testing

Improving Diabetes Outcomes for People With Severe Mental Illness (SMI)

Who this might be right for
Diabetes Mellitus, Type 2Severe Mental Disorder
University of York 46,564
Large-scale testing (Phase 3)Study completedNCT00566735
What this trial is testing

The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning

Who this might be right for
Major DepressionBipolar DepressionSchizoaffective Disorder
Massachusetts General Hospital 39
Testing effectiveness (Phase 2)Study completedNCT00401089
What this trial is testing

Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderTardive Dyskinesia+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Large-scale testing (Phase 3)Ended earlyNCT00725270
What this trial is testing

Treatment of Schizoaffective Disorder Using Mifepristone

Who this might be right for
Psychotic DisordersDepressive Disorder, MajorDepressive Disorder
Stanford University 12
Next Page